Funder: Bill and Melinda Gates Foundation
Due Dates (Anticipated): April 2026 | October 2026
Funding Amounts: Phase I grants: $100,000 USD for 18 months; potential for follow-on Phase II funding.
Summary: Supports innovative research to improve understanding, diagnosis, and treatment of heavy menstrual bleeding in women and girls in low-resource settings.